How JNJ Gets To $85 Billion: Devices, Pharma, or Consumer?
- Friday, March 6, 2020, 7:12
- Market
- Add a comment
Johnson & Johnson (NYSE: JNJ) revenue grew at a CAGR of 4.1% from $70.0 billion in 2015 to $82.0 billion in 2019, and it is estimated to top $85 billion in 2020, led by its pharmaceuticals business, which is expected to be the single-biggest revenue driver with $44.8 billion in revenues…
About the Author
admin123 has written 23427 stories on this site.
